Skip to main content
Caplight Logo









Amyndas Pharmaceuticals

Amyndas Pharmaceuticals

Private
Jackson, WyomingHealthcare & Life Scienceshttps://amyndas.com

Company Overview

Amyndas Pharmaceuticals operates in Healthcare & Life Sciences and is based in Jackson, Wyoming. It was founded in 2013.

Amyndas Pharmaceuticals is a biopharmaceutical company developing complement therapeutics for the treatment of inflammatory diseases and disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Amyndas Pharmaceuticals Comparables

Compare Amyndas Pharmaceuticals with similar companies based on industry and business-model similarity.

Amyndas Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NovelMed Therapeutics
84%
Kira Pharmaceuticals
80%
Arrowhead Pharmaceuticals
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Amyndas Pharmaceuticals Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Amyndas Pharmaceuticals. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 298% MoM to 1.3K.

  • May 4, 2025

    Monthly visitors grew 136% MoM, reaching 1.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Amyndas Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Amyndas Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Amyndas Pharmaceuticals's valuation, stock price, and market status.

Is Amyndas Pharmaceuticals a public or private company?

Amyndas Pharmaceuticals is a private company.

What is the current stock price of Amyndas Pharmaceuticals?

Amyndas Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Amyndas Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Amyndas Pharmaceuticals worth (valuation)?

Valuation information for Amyndas Pharmaceuticals is not publicly available.

Can I buy Amyndas Pharmaceuticals stock?

Amyndas Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Amyndas Pharmaceuticals's last funding round?

Funding round information for Amyndas Pharmaceuticals is not publicly available.

Who are the main investors in Amyndas Pharmaceuticals?

Investor information for Amyndas Pharmaceuticals is not publicly disclosed.

Will Amyndas Pharmaceuticals IPO soon?

No public IPO plans have been announced for Amyndas Pharmaceuticals.

How can I track Amyndas Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades in Amyndas Pharmaceuticals's shares on secondary markets.

Firmographic Details

HeadquartersJackson, Wyoming
Employee Range1
Year Founded2013
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?